https://biotechmorning.com/news/glp1-drugs-cancer-risk-reduction-asco-2026 Biotech Morning en 2026-06-10T14:27:45.218Z Ozempic Might Fight Cancer. ASCO Just Dropped the Receipts. https://biotechmorning.com/news/gilead-trodelvy-nsclc-lung-cancer-failure Biotech Morning en 2026-06-10T14:26:54.780Z Gilead Spent $21 Billion on a Drug That Can't Crack Lung Cancer https://biotechmorning.com/news/daraxonrasib-ras-cancer-survival-breakthrough Biotech Morning en 2026-06-10T14:25:54.273Z The Cancer Target That Stumped Scientists for 40 Years Just Got Cracked Wide Open https://biotechmorning.com/news/lilly-haisco-3-billion-china-deal Biotech Morning en 2026-06-10T14:25:03.649Z Lilly Just Wrote a $3 Billion Check to a Chinese Biotech You've Never Heard Of https://biotechmorning.com/news/fda-approves-bemotrizinol-first-new-sunscreen-ingredient-20-years Biotech Morning en 2026-06-10T14:24:06.633Z America's Sunscreen Has Been Stuck in 1999. That Just Changed. https://biotechmorning.com/news/japan-approves-telomelysin-cancer-killing-virus Biotech Morning en 2026-06-10T14:23:11.723Z Japan Just Approved a Cancer-Killing Virus. Yes, You Read That Right. https://biotechmorning.com/news/novartis-orionis-molecular-glue-deal Biotech Morning en 2026-06-10T14:22:20.234Z Why Novartis Keeps Writing Billion-Dollar Checks to This Biotech https://biotechmorning.com/news/fda-meeting-killed-fulcrum-therapeutics Biotech Morning en 2026-06-10T14:21:21.214Z One FDA Meeting Killed This Entire Biotech Company https://biotechmorning.com/news/bepirovirsen-hepatitis-b-functional-cure-phase-3 Biotech Morning en 2026-06-10T14:20:19.461Z The 6-Month Shot That Could Let Millions Ditch Daily Hep B Pills https://biotechmorning.com/news/pentagon-blacklist-wuxi-apptec-biotech-supplier Biotech Morning en 2026-06-10T14:19:18.624Z The Pentagon Just Dropped a Bomb on Biotech's Favorite Supplier https://biotechmorning.com/news/ivonescimab-beats-pd1-inhibitor-overall-survival-squamous-nsclc Biotech Morning en 2026-06-10T14:18:17.152Z The Two-in-One Cancer Drug That Just Beat the Gold Standard https://biotechmorning.com/news/parabilis-medicines-ipo-800m-startup Biotech Morning en 2026-06-09T14:29:17.246Z The $800M Startup That Still Needs Half a Billion More https://biotechmorning.com/news/astrazeneca-oral-glp1-comeback Biotech Morning en 2026-06-09T14:28:28.867Z AstraZeneca Wants Into the GLP-1 Business. And the Pill They're Betting On Just Posted Real Data. https://biotechmorning.com/news/jnj-billion-dollar-firefly-bio-dac-acquisition Biotech Morning en 2026-06-09T14:27:32.654Z J&J Just Paid $1 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/gsk-nuvalent-10-billion-oncology-acquisition Biotech Morning en 2026-06-09T14:26:41.471Z GSK Just Wrote a $10.6 Billion Check for Two Drugs That Don't Exist Yet https://biotechmorning.com/news/hympavzi-fda-expansion-pediatric-hemophilia-inhibitors Biotech Morning en 2026-06-09T14:25:50.181Z The Shot That Could Replace IV Drips for Kids With Hemophilia https://biotechmorning.com/news/tango-therapeutics-pancreatic-cancer-breakthrough Biotech Morning en 2026-06-09T14:24:58.534Z The Cancer That Kills Almost Everyone Just Met Its Worst Nightmare https://biotechmorning.com/news/venglustat-brain-barrier-gaucher-type-3 Biotech Morning en 2026-06-09T14:24:03.894Z The Pill That Crosses the Brain's Toughest Bouncer https://biotechmorning.com/news/afrezza-inhaled-insulin-pediatric-approval Biotech Morning en 2026-06-09T14:23:12.570Z The Insulin That Kids Don't Have to Stab Themselves With https://biotechmorning.com/news/hiv-pill-came-back-from-the-dead Biotech Morning en 2026-06-09T14:22:15.977Z The HIV Pill That Came Back From the Dead